319 related articles for article (PubMed ID: 26757900)
1. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
[TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from statin-modified bone marrow dendritic cells increase thymus-derived natural regulatory T cells in experimental autoimmune myasthenia gravis.
Zhang P; Liu RT; Du T; Yang CL; Liu YD; Ge MR; Zhang M; Li XL; Li H; Dou YC; Duan RS
J Neuroinflammation; 2019 Nov; 16(1):202. PubMed ID: 31679515
[TBL] [Abstract][Full Text] [Related]
4. Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis.
Li H; Wang CC; Zhang M; Li XL; Zhang P; Yue LT; Miao S; Wang S; Liu Y; Li YB; Duan RS
Mol Cell Neurosci; 2015 Sep; 68():284-92. PubMed ID: 26311508
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
[TBL] [Abstract][Full Text] [Related]
6. Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.
Wang CC; Li H; Zhang M; Li XL; Yue LT; Zhang P; Zhao Y; Wang S; Duan RN; Li YB; Duan RS
J Neuroinflammation; 2015 Jun; 12():118. PubMed ID: 26071315
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
J Neuroinflammation; 2019 Jun; 16(1):119. PubMed ID: 31171009
[TBL] [Abstract][Full Text] [Related]
8. Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.
Yin W; Ouyang S; Luo Z; Zeng Q; Hu B; Xu L; Li Y; Xiao B; Yang H
Inflammation; 2017 Aug; 40(4):1460-1473. PubMed ID: 28523463
[TBL] [Abstract][Full Text] [Related]
9. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
[TBL] [Abstract][Full Text] [Related]
10. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
[TBL] [Abstract][Full Text] [Related]
11. Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways.
Xu H; Zhang M; Li XL; Li H; Yue LT; Zhang XX; Wang CC; Wang S; Duan RS
J Neuroimmunol; 2015 Apr; 281():61-7. PubMed ID: 25867469
[TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
Aricha R; Reuveni D; Fuchs S; Souroujon MC
J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
[TBL] [Abstract][Full Text] [Related]
13. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway.
Lu Y; Ma Q; Yu L; Huang H; Liu X; Chen P; Ran H; Liu W
Int Immunopharmacol; 2023 Feb; 115():109693. PubMed ID: 36638660
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.
Adikari SB; Lian H; Link H; Huang YM; Xiao BG
Clin Exp Immunol; 2004 Nov; 138(2):230-6. PubMed ID: 15498031
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
[TBL] [Abstract][Full Text] [Related]
16. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Aricha R; Mizrachi K; Fuchs S; Souroujon MC
J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells.
Xu H; Li XL; Yue LT; Li H; Zhang M; Wang S; Wang CC; Duan RS
J Neuroimmunol; 2014 Apr; 269(1-2):28-37. PubMed ID: 24565076
[TBL] [Abstract][Full Text] [Related]
18. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of artesunate in experimental autoimmune myasthenia gravis by upregulated T regulatory cells and regulation of Th1/Th2 cytokines.
Meng QF; Zhang XX; Zhang Z; Chen W; Li XL; Wang YJ; Li FF; Li YB
Pharmazie; 2018 Sep; 73(9):526-532. PubMed ID: 30223936
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
